Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis.


Journal

PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755

Informations de publication

Date de publication:
02 May 2024
Historique:
received: 23 12 2023
accepted: 05 04 2024
medline: 2 5 2024
pubmed: 2 5 2024
entrez: 2 5 2024
Statut: aheadofprint

Résumé

BAK and BAX execute intrinsic apoptosis by permeabilising the mitochondrial outer membrane. Their activity is regulated through interactions with pro-survival BCL-2 family proteins and with non-BCL-2 proteins including the mitochondrial porin VDAC2. VDAC2 is important for bringing both BAK and BAX to mitochondria where they execute their apoptotic function. Despite this important function in apoptosis, while interactions with pro-survival family members are well characterised and have culminated in the development of drugs that target these interfaces to induce cancer cell apoptosis, the interaction between BAK and VDAC2 remains largely undefined. Deep scanning mutagenesis coupled with cysteine linkage identified key residues in the interaction between BAK and VDAC2. Obstructive labelling of specific residues in the BH3 domain or hydrophobic groove of BAK disrupted this interaction. Conversely, mutating specific residues in a cytosol-exposed region of VDAC2 stabilised the interaction with BAK and inhibited BAK apoptotic activity. Thus, this VDAC2-BAK interaction site can potentially be targeted to either inhibit BAK-mediated apoptosis in scenarios where excessive apoptosis contributes to disease or to promote BAK-mediated apoptosis for cancer therapy.

Identifiants

pubmed: 38696533
doi: 10.1371/journal.pbio.3002617
pii: PBIOLOGY-D-23-03432
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3002617

Informations de copyright

Copyright: © 2024 Yuan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Zheng Yuan (Z)

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.
Department of Medical Biology, University of Melbourne, Parkville, Melbourne, Australia.

Mark F van Delft (MF)

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.
Department of Medical Biology, University of Melbourne, Parkville, Melbourne, Australia.

Mark Xiang Li (MX)

Peter MacCallum Cancer Centre, Parkville, Melbourne, Australia.

Fransisca Sumardy (F)

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.

Brian J Smith (BJ)

La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia.

David C S Huang (DCS)

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.
Department of Medical Biology, University of Melbourne, Parkville, Melbourne, Australia.

Guillaume Lessene (G)

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.
Department of Medical Biology, University of Melbourne, Parkville, Melbourne, Australia.
Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Melbourne, Australia.

Yelena Khakam (Y)

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.

Ruitao Jin (R)

La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia.
Research School of Biology, Australian National University, Canberra, Australia.

Sitong He (S)

La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia.

Nicholas A Smith (NA)

La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia.

Richard W Birkinshaw (RW)

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.
Department of Medical Biology, University of Melbourne, Parkville, Melbourne, Australia.

Peter E Czabotar (PE)

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.
Department of Medical Biology, University of Melbourne, Parkville, Melbourne, Australia.

Grant Dewson (G)

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.
Department of Medical Biology, University of Melbourne, Parkville, Melbourne, Australia.

Classifications MeSH